catalyst
as of 2026-07-01Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schi — primary completion
at a glance
2017-07-21 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schi — primary completion
Type
Trial Readout
Date
2017-07-21
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here